Cequa (ciclosporin 900 microgram/mL) is a newly-approved immunosuppressant indicated to increase tear production in affected patients where prior use of artificial tears has not been sufficient.
Read More
New dry eye therapy now TGA-approved
Australian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye.
Read More
Read More